Page last updated: 2024-10-24

candesartan cilexetil and Hyperinsulinism

candesartan cilexetil has been researched along with Hyperinsulinism in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.

Research Excerpts

ExcerptRelevanceReference
"We have previously demonstrated that captopril ameliorates glucose intolerance by partially preventing the reduction in postprandial skeletal muscle blood flow."7.69Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. ( Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I, 1996)
"We have previously demonstrated that captopril ameliorates glucose intolerance by partially preventing the reduction in postprandial skeletal muscle blood flow."3.69Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. ( Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, S1
Kashiwabara, H1
Kosegawa, I1
Ishii, J1
Katayama, S1

Other Studies

1 other study available for candesartan cilexetil and Hyperinsulinism

ArticleYear
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1996, Volume: 18, Issue:5

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv

1996